Skip to main content

Using the MAGIC Algorithm Probability (MAP) to Guide Acute GVHD Treatment

  • The biology of the biomarkers used in the aGVHD Algorithm assays
  • How MAGIC Algorithm Probability (MAP) testing classifies patients for long term risk of severe GVHD and non-relapse mortality identify in pre-symptomatic, symptom onset, and post-treatment HCT patients
  • How to interpret MAPs as response biomarkers
  • Case studies recommending treatment approaches guided by MAPs

Length of Presentation: 56 minutes (part 2 of 4)

Presented by: 

  • Dr. James Ferrara, MD
    Ward-Coleman Chair in Cancer Medicine
    Professor of Pediatrics & Medicine
    Icahn School of Medicine at Mount Sinai
  • Dr. Ryotaro Nakamura, MD
    Hematologist - Oncologist
    Associate Professor of Department of Hematology & Hematopoietic Cell Transplantation; Co-director, Center for Stem Cell Transplantation
Back to top